The outcomes of a pooled analysis of plasma IL-10 concentrations in patients are illustrated in Figure 2A. The results indicated that no difference in the plasma levels of IL-10 was detected between OSAHS patients and controls (SMD = −0.68, 95% CI = −1.58 to 0.21, P = .136). The gene discussed is IL10; the disease is obstructive sleep apnea syndrome.